For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| OV101 BID | OV101 15 mg Evening OV101 10 mg Morning | 0 | None | 1 | 29 | 19 | 29 | View |
| Placebo | Placebo Morning and Evening | 0 | None | 0 | 29 | 13 | 29 | View |
| OV101 QD | OV101 15mg Evening | 0 | None | 1 | 29 | 18 | 29 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Seizure | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| General disorders and administration site conditions | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Somnolence | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Seizure | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Lethargy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Aggression | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Insomnia | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Agitation | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Sleep disorder | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Myoclonic epilepsy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Myoclonus | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Irritability | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |